CONCERTA 36mg price in UAE

Overview

Welcome to Dwaey, specifically on CONCERTA 36mg Tablets/Modified Release page.
This medicine contains an important and useful components, as it consists of Methylphenidate (HCl).
CONCERTA 36mg is available in the market in concentration 36mg/Tablet and in the form of Tablets/Modified Release.

JANSSEN CILAG MANUFACTURING, LLC is the producer of CONCERTA 36mg and it is imported from USA, The most popular alternatives of CONCERTA 36mg are listed downward .

Mode Of Action

Methylphenidate is a central stimulant and indirect-acting sympathomimetic.

Indication

Narcolepsy
Attention Deficit Hyperactivity Disorder

Precaution

Pregnancy and lactation. History of alcohol or drug abuse. Hypertension and other CV disorders that might be exacerbated by increases in BP or heart rate. Pre-existing psychosis or bipolar disorder; monitor for symptoms of aggression or hostility. History of seizure disorder. Children <6 yr (growth suppression); monitor growth during therapy. May impair ability to drive or operate machinery. Transdermal: Avoid exposure of application site to any direct external heat source. Lactation: Unknown; avoid during breastfeeding; use caution

Side Effects

Angina
arrhythmia
cerebral arteritis
cerebral occlusion
changes in BP
MI
necrotising vasculitis
palpitation
pulse changes
tachycardia; depression
dizziness
drowsiness
fever
headache
insomnia
nervousness
neuroleptic malignant syndrome (NMS)
Tourette's syndrome
toxic psychosis; erythema multiforme
exfoliative dermatitis
hair loss
rash
urticaria; growth retardation; abdominal pain
anorexia
diarrhoea
nausea
vomiting
weight loss; anaemia
leukopenia
thrombocytopenic purpura
thrombocytopenia; abnormal LFTs
hepatic coma
increased transaminases; arthralgia
dyskinesia; blurred vision
visual accommodation disturbance; cough
pharyngitis
sinusitis
upper respiratory tract infection; accidental injury
hypersensitivity. Transdermal: Insomnia
decreased appetite; nausea; tic
emotional instability; vomiting
anorexia; nasal congestion
nasopharyngitis; weight loss.

Contra indication

Marked anxiety, tension, agitation; glaucoma; Tourette's syndrome or tics. Known severe structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac disorders that could increase the risk of sudden death. Extended-release form: Severe hypertension, heart failure, arrhythmia, hyperthyroidism, recent MI or angina.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

May reduce effects of antihypertensive agents. Reduced serum level with carbamazepine. Increased serum levels or effects with CYP2D6 inhibitors e.g. chlorpromazine, delavirdine, fluoxetine, miconazole, paroxetine, pergolide, quinidine, quinine, ritonavir, ropinirole. May increase serum levels of phenytoin, TCAs. Possible severe hypertension and tachycardia with sibutramine. CNS depression with alcohol. Potentially Fatal: Severe toxic reactions with clonidine. Increased risk of hypertensive crisis with MAOIs.